BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36413684)

  • 21. Sickle cell disease in pregnancy: maternal complications in a Medicaid-enrolled population.
    Boulet SL; Okoroh EM; Azonobi I; Grant A; Craig Hooper W
    Matern Child Health J; 2013 Feb; 17(2):200-7. PubMed ID: 23315242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maternal/Perinatal Outcome in Women with Sickle Cell Disease: A Comparison of Two Time Periods.
    Chang JN; Magann EF; Novotny SA; Cooley CE; Gauss CH; Parrish MR; Morrison JC
    South Med J; 2018 Dec; 111(12):742-745. PubMed ID: 30512127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pregnancy in the Sickle Cell Disease and Fetomaternal Outcomes in Different Sickle cell Genotypes: A Systematic Review and Meta-Analysis.
    Aghamolaei T; Pormehr-Yabandeh A; Hosseini Z; Roozbeh N; Arian M; Ghanbarnezhad A
    Ethiop J Health Sci; 2022 Jul; 32(4):849-864. PubMed ID: 35950054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The obstetric performance of sickle cell disease patients and homozygous hemoglobin C disease patients in Ile-Ife, Nigeria.
    Dare FO; Makinde OO; Faasuba OB
    Int J Gynaecol Obstet; 1992 Mar; 37(3):163-8. PubMed ID: 1351002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pregnancy outcome in patients with homozygous sickle cell disease in a university hospital, Eastern Saudi Arabia.
    Al Jama FE; Gasem T; Burshaid S; Rahman J; Al Suleiman SA; Rahman MS
    Arch Gynecol Obstet; 2009 Nov; 280(5):793-7. PubMed ID: 19271230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current obstetric outcomes in Jamaican women with sickle hemoglobinopathy - a balance of risks for aspirin?
    Gibson SMP; Hunter TA; Charles PE; Morgan MAC; Griffith-Anderson SKR; Cruickshank JK; Gossell-Williams MD; Johnson NA
    J Perinat Med; 2024 Jun; 52(5):485-493. PubMed ID: 38629833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome of pregnancies among women with sickle cell disease.
    Nkwabong E; Ngoundjou Dongmo P; Tayou C; Nana Njamen T
    J Matern Fetal Neonatal Med; 2022 Mar; 35(6):1108-1112. PubMed ID: 32233705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maternal and perinatal outcome of women with sickle cell disease of a tribal population in Central India.
    Natu N; Khandelwal S; Kumar R; Dave A
    Hemoglobin; 2014; 38(2):91-4. PubMed ID: 24417305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prophylactic red blood cell exchange may be beneficial in the management of sickle cell disease in pregnancy.
    Asma S; Kozanoglu I; Tarım E; Sarıturk C; Gereklioglu C; Akdeniz A; Kasar M; Turgut NH; Yeral M; Kandemir F; Boga C; Ozdogu H
    Transfusion; 2015 Jan; 55(1):36-44. PubMed ID: 25070465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pregnancy in sickle cell disease in the UK: results of a multicentre survey of the effect of prophylactic blood transfusion on maternal and fetal outcome.
    Howard RJ; Tuck SM; Pearson TC
    Br J Obstet Gynaecol; 1995 Dec; 102(12):947-51. PubMed ID: 8652484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome of pregnancy in sickle cell anemia and sickle cell-hemoglobin C disease. An analysis of 181 pregnancies in 98 patients, and a review of the literature.
    Milner PF; Jones BR; Döbler J
    Am J Obstet Gynecol; 1980 Oct; 138(3):239-45. PubMed ID: 7416213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current management of sickle cell disease in pregnancy.
    Andemariam B; Browning SL
    Clin Lab Med; 2013 Jun; 33(2):293-310. PubMed ID: 23702119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The emerging challenge of optimal blood pressure management and hypertensive syndromes in pregnant women with sickle cell disease: a review.
    Lari NF; DeBaun MR; Oppong SA
    Expert Rev Hematol; 2017 Nov; 10(11):987-994. PubMed ID: 28905692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A study of 28 pregnant women with sickle cell disease and COVID-19: elevated maternal and fetal morbidity rates.
    Joseph L; De Luna G; Bernit E; Cougoul P; Santin A; Faucher B; Habibi A; Garou A; Loko G; Mattioni S; Manceau S; Arlet JB; Lionnet F
    Haematologica; 2024 May; 109(5):1562-1565. PubMed ID: 37855041
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparative studies of live neonates in maternal sickle cell haemoglobinopathy in Ghana.
    Addai FK; Wilson JB; Quashie FJ
    Trop Geogr Med; 1992 Oct; 44(4):312-6. PubMed ID: 1295139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse maternal and perinatal outcomes in pregnant women with sickle cell disease: systematic review and meta-analysis.
    Oteng-Ntim E; Meeks D; Seed PT; Webster L; Howard J; Doyle P; Chappell LC
    Blood; 2015 May; 125(21):3316-25. PubMed ID: 25800049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How I treat sickle cell disease in pregnancy.
    James AH; Strouse JJ
    Blood; 2024 Feb; 143(9):769-776. PubMed ID: 37979134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A call for policy action in sub-Saharan Africa to rethink diagnostics for pregnancy affected by sickle cell disease: differential views of medical doctors, parents and adult patients predict value conflicts in Cameroon.
    Wonkam A; Hurst S
    OMICS; 2014 Jul; 18(7):472-80. PubMed ID: 24754796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sickle cell disease and pregnancy outcomes: women of African descent.
    Barfield WD; Barradas DT; Manning SE; Kotelchuck M; Shapiro-Mendoza CK
    Am J Prev Med; 2010 Apr; 38(4 Suppl):S542-9. PubMed ID: 20331956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pregnancy in sickle cell disease.
    Powars DR; Sandhu M; Niland-Weiss J; Johnson C; Bruce S; Manning PR
    Obstet Gynecol; 1986 Feb; 67(2):217-28. PubMed ID: 3945432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.